| Dr Agnes Usoro, MD | |
|
5755 Cedar Ln, Columbia, MD 21044-2999 | |
| (410) 740-7890 | |
| Not Available |
| Full Name | Dr Agnes Usoro |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 5755 Cedar Ln, Columbia, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316300106 | NPI | - | NPPES |
| D87725 | Other | MD | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | D87725 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Howard County General Hospital | Columbia, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
Researchers have found that an enzyme in the bacteria that causes cholera uses a previously unknown mechanism in providing the bacteria with energy. Because the enzyme is not found in most other organisms, including humans, the finding offers insights into how drugs might be created to kill the bacteria without harming humans.
As lawmakers debate health care reform, business innovator Lou Weisbach and Clinton White House health care advisor Dr. Richard Boxer are available for interviews to discuss a glaring, missing element of the forthcoming health care legislation: reducing health care costs - and saving lives - by preventing and curing disease.
Using a new cellular model, innovative gene therapy approaches for the hereditary immunodeficiency Chronic Granulomatous Disease can be tested faster and cost-effectively in the lab for their efficacy.
Confluent Surgical, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the DuraSeal Dural Sealant System as the first and only product indicated as an adjunct to sutured dural repair during cranial surgery to achieve watertight closure. The FDA has approved the DuraSeal Sealant with a condition to conduct a post-approval study.
› Verified 5 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Researchers have found that an enzyme in the bacteria that causes cholera uses a previously unknown mechanism in providing the bacteria with energy. Because the enzyme is not found in most other organisms, including humans, the finding offers insights into how drugs might be created to kill the bacteria without harming humans.
As lawmakers debate health care reform, business innovator Lou Weisbach and Clinton White House health care advisor Dr. Richard Boxer are available for interviews to discuss a glaring, missing element of the forthcoming health care legislation: reducing health care costs - and saving lives - by preventing and curing disease.
Using a new cellular model, innovative gene therapy approaches for the hereditary immunodeficiency Chronic Granulomatous Disease can be tested faster and cost-effectively in the lab for their efficacy.
Confluent Surgical, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the DuraSeal Dural Sealant System as the first and only product indicated as an adjunct to sutured dural repair during cranial surgery to achieve watertight closure. The FDA has approved the DuraSeal Sealant with a condition to conduct a post-approval study.
› Verified 5 days ago
| Entity Name | Emergency Medicine Associates Pa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134117393 PECOS PAC ID: 8022914522 Enrollment ID: O20040126000955 |
News Archive
Researchers have found that an enzyme in the bacteria that causes cholera uses a previously unknown mechanism in providing the bacteria with energy. Because the enzyme is not found in most other organisms, including humans, the finding offers insights into how drugs might be created to kill the bacteria without harming humans.
As lawmakers debate health care reform, business innovator Lou Weisbach and Clinton White House health care advisor Dr. Richard Boxer are available for interviews to discuss a glaring, missing element of the forthcoming health care legislation: reducing health care costs - and saving lives - by preventing and curing disease.
Using a new cellular model, innovative gene therapy approaches for the hereditary immunodeficiency Chronic Granulomatous Disease can be tested faster and cost-effectively in the lab for their efficacy.
Confluent Surgical, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the DuraSeal Dural Sealant System as the first and only product indicated as an adjunct to sutured dural repair during cranial surgery to achieve watertight closure. The FDA has approved the DuraSeal Sealant with a condition to conduct a post-approval study.
› Verified 5 days ago
| Entity Name | Johns Hopkins Emergency Medical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922098466 PECOS PAC ID: 3577546753 Enrollment ID: O20040609000834 |
News Archive
Researchers have found that an enzyme in the bacteria that causes cholera uses a previously unknown mechanism in providing the bacteria with energy. Because the enzyme is not found in most other organisms, including humans, the finding offers insights into how drugs might be created to kill the bacteria without harming humans.
As lawmakers debate health care reform, business innovator Lou Weisbach and Clinton White House health care advisor Dr. Richard Boxer are available for interviews to discuss a glaring, missing element of the forthcoming health care legislation: reducing health care costs - and saving lives - by preventing and curing disease.
Using a new cellular model, innovative gene therapy approaches for the hereditary immunodeficiency Chronic Granulomatous Disease can be tested faster and cost-effectively in the lab for their efficacy.
Confluent Surgical, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the DuraSeal Dural Sealant System as the first and only product indicated as an adjunct to sutured dural repair during cranial surgery to achieve watertight closure. The FDA has approved the DuraSeal Sealant with a condition to conduct a post-approval study.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Agnes Usoro, MD Po Box 418937, Boston, MA 02241-8937 Ph: (410) 259-9987 | Dr Agnes Usoro, MD 5755 Cedar Ln, Columbia, MD 21044-2999 Ph: (410) 740-7890 |
News Archive
Researchers have found that an enzyme in the bacteria that causes cholera uses a previously unknown mechanism in providing the bacteria with energy. Because the enzyme is not found in most other organisms, including humans, the finding offers insights into how drugs might be created to kill the bacteria without harming humans.
As lawmakers debate health care reform, business innovator Lou Weisbach and Clinton White House health care advisor Dr. Richard Boxer are available for interviews to discuss a glaring, missing element of the forthcoming health care legislation: reducing health care costs - and saving lives - by preventing and curing disease.
Using a new cellular model, innovative gene therapy approaches for the hereditary immunodeficiency Chronic Granulomatous Disease can be tested faster and cost-effectively in the lab for their efficacy.
Confluent Surgical, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the DuraSeal Dural Sealant System as the first and only product indicated as an adjunct to sutured dural repair during cranial surgery to achieve watertight closure. The FDA has approved the DuraSeal Sealant with a condition to conduct a post-approval study.
› Verified 5 days ago
Dr. Wynne Breed, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7777 Fax: 410-740-7551 | |
Mayuri Patel, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 443-718-3737 | |
Danielle K Matilsky, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-720-8482 | |
Levan Kuck, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-550-9720 | |
Dr. Igor Kukelyansky, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 443-540-2277 | |
Selamawit Getachew, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-550-9720 | |
Andrea Ceresa Ridgeway, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-8787 |